In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients.

The in vitro activity of sparfloxacin, a new quinolone, was compared with those of ciprofloxacin and fleroxacin against gram-positive and gram-negative bacteria, greater than 90% of which were isolated from blood culture specimens of cancer patients. Sparfloxacin was extremely active against Acineto...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Rolston, K V, Nguyen, H, Messer, M, LeBlanc, B, Ho, D H, Bodey, G P
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1990
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172035/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2127348/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.11.2263
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!